Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2026-06-08 @ 1:32 AM
Study NCT ID:
NCT01328002
Status:
TERMINATED
Last Update Posted:
2019-05-14
First Post:
2011-03-31
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia
Sponsor:
Forest Laboratories
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Primary Fibromyalgia | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Fibromyalgia | View |
| None | Pediatric Fibromyalgia | View |
| None | Adolescent Fibromyalgia | View |
| None | milnacipran | View |
| None | Savella | View |
| None | loss of therapeutic response | View |
| None | Forest Research Institute | View |
| None | Pain | View |
| None | Fatigue | View |
| None | Serotonin Norepinephrine Reuptake Inhibitors | View |
| None | Randomized Withdrawal | View |